SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891293-17-000080
Filing Date
2017-07-24
Accepted
2017-07-24 16:42:02
Documents
3
Period of Report
2017-07-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kfischer.htm 8-K 38112
2 EXHIBIT 99.1 ex991fischer.htm EX-99.1 9535
3 image0a02.jpg GRAPHIC 5054
  Complete submission text file 0000891293-17-000080.txt   56051
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-28386 | Film No.: 17978649
SIC: 2834 Pharmaceutical Preparations